Abstract
Induction of labor is common in obstetric practice. According to the most current studies, the rate varies from 9.5 to 33.7 percent of all pregnancies annually. Cervical ripening is necessary for a successful vaginal delivery. This study shows shorter labour stages I and III, and less blood loss in mifepristone group. The drug has no significant effects on uterine contraction and no serious maternal complications. This drug has a safe neonatal outcome. Patient can remain ambulatory, which is very convenient as compared to PGE2 gel. PgE2 gel needs refrigerator for storage and skill for intracervical insertion with strict aseptic technique. Hence mifepristone offers advantages over PGE2 gel which is currently used for preinduction cervical ripening.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
